Navigation Links
Justifying the use of letrozole for inducing ovulation

Letrozole used for the treatment of advanced/metastatic breast cancer in postmenopausal women is also being used by // infertility specialists as a second line of treatment for infertility for inducing ovulation. Studies indicate that letrozole was used not on an experimental basis, but as an accepted safe drug for inducing ovulation.

However some feel that without clinical trials to ascertain any possible side effect, prescribing the drug Letrozole for infertility is unethical and illegal. Another argument is that, since the drug is used for a short duration of 5 days its effect is short acting and the side effects would be minimum or practically nil. It is also said that since the drug is administered before ovulation and fertilization, there is no question of teratogenicity (malformation of the fetus) when compared to injectible gonado tropins used for treating infertility which are associated with a higher incidence of multiple pregnancies.

It is argued that the practice of medicine is regulated by Medical Council of India, and not by the Drugs Controller hence they feel that drug controller can introduce a new drug for marketing, or ban a particular drug from being sold but should not be given the right to designate a particular drug for a particular disease, to be prescribed by a particular section of doctors.

Letrozole could be prescribed only for treating breast cancer and not for inducing ovulation as per the permission given by the Drugs Controller General of India (DCGI). However it is said that doctors cannot be asked not to prescribe it , instead ask the drug store owners not to honor any prescriptions violating existing norms stipulated by the Drugs Controller's office.

A doctor specializing in oncology and women's diseases from a city based hospital 'A cure for incurable ‘, says that the use of letrozole in a healthy women if used for ovulation may lead to developing cancer of ovary, breast or any other part of the body and the chance is one in every one thousand. Hence he concludes saying that homeopathic medicines are better alternatives for inducing ovulation as they do not have any side effect.
'"/>




Related medicine news :

1. Therapy inducing self-repair of nerves to help Alzheimer’
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... CO (PRWEB) , ... December 02, 2016 , ... Advanced ... announced it has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief ... for Advanced, Inc. , Jason brings extensive financial and operational leadership experience to ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... ... 02, 2016 , ... Mediaplanet’s newest campaign, “Digestive Heath,” hits ... proof that attitude and determination can combine into the most remarkable achievements. Over ... holidays. This campaign will offer patients a new-found hope, by seizing the opportunity ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is ... USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that ... “We are prolonging life 6 years in the last 3 decades,” says Dr. ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... veterinarian diagnostic imaging systems and the first company to offer robotic imaging ... Heart at their tradeshow booth # 941 for the American Association of Equine ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016 Lianluo Smart Limited ... "the Company") which develops, markets and sells medical ... China and international markets, recently ... and Treatment New Progress Forum, co-hosted by the ... Province , Guangdong Provincial People,s Hospital and ...
(Date:12/2/2016)... Dec. 1, 2016 The concept of rare diseases ... given to this sector has been taking shape in ... the political aspects and initiatives related to orphan medicinal products ... the level of member states individually. Many member states in ... the space of orphan medicinal products, the result of which ...
(Date:12/2/2016)... Allergan plc (NYSE: AGN ), a ... previously announced Accelerated Share Repurchase (ASR) Program. Logo - ... ... previously announced, the Company entered into a variable tenor ASR ... repurchase $10 billion of its ordinary shares. Approximately 40.5 million ...
Breaking Medicine Technology: